Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches.

Cakir, Merve; Obernier, Kirsten; Forget, Antoine; Krogan, Nevan J

Cakir, Merve; Obernier, Kirsten; Forget, Antoine; Krogan, Nevan J.

Afiliação

Cakir M; Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA.
Obernier K; Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, California, USA.
Forget A; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA.
Krogan NJ; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, California, USA.

mSystems ; 6(5): e0038821, 2021 Oct 26.

Article em En | MEDLINE | ID: mdl-34519533

Palavras-chave

drug repurposing; host-directed therapies; host-pathogen interactions; proteomics; systems biology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MSystems Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google